— Know what they know.
Not Investment Advice

LBLTF OTC

Lattice Biologics Ltd.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -99.4% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 49 · $16545 mcap · 105M float · 0.0010% daily turnover

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
29
Earnings Quality
42
Growth
48
Value
15
Momentum
50
Safety
0
Cash Flow
41

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-21.78
Distress Zone
Piotroski F-Score
4/9
✗ ✗ ✓ ✓ ✓ ✗ ✗ ✗ ✓
Beneish M-Score
—
—
Ohlson O-Score
inf
Bankruptcy prob: 100.0%
High Risk
Credit Rating
B-
Score: 21.3/100
Trend: Improving
Earnings Quality
—
OCF/NI: 0.14x
Accruals: -51.3%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LBLTF scores -21.78, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LBLTF scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LBLTF's implied 100.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LBLTF receives an estimated rating of B- (score: 21.3/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.01x
PEG
-0.00x
P/S
0.01x
P/B
-0.00x
P/FCF
-4.58x
P/OCF
—
EV/EBITDA
160.92x
EV/Revenue
2.06x
EV/EBIT
-9.12x
EV/FCF
-4.58x
Earnings Yield
-28.79%
FCF Yield
-21.83%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. LBLTF currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
2.626
EBT / EBIT
×
EBIT Margin
-0.226
EBIT / Rev
×
Asset Turnover
1.010
Rev / Assets
×
Equity Multiplier
-0.459
Assets / Equity
=
ROE
27.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LBLTF's ROE of 27.4% is driven by Asset Turnover (1.010), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
615.4%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
ROE 1.6% 1.0% 86.5% 45.1% 30.0% 8.6% -6.4% 43.6% 25.7% 24.8% 18.8% 12.1% 17.4% 16.4% 29.9% 30.7% 23.3% 25.8% 27.6% 27.4% 27.45%
ROA -1.5% -1.0% -98.2% -47.5% -37.8% -11.1% 9.0% -51.0% -37.8% -37.6% -28.9% -21.7% -37.9% -34.8% -67.7% -70.7% -56.0% -63.0% -82.0% -59.8% -59.82%
ROIC 81.1% 79.7% 62.4% 1.9% 1.0% 82.1% 71.2% 59.3% 31.8% 35.2% 19.5% 13.5% 10.6% 10.3% 13.8% 16.6% 8.0% 11.6% 39.8% -4.8% -4.83%
ROCE 2.1% 1.3% 92.9% 75.1% -15.9% -48.0% -70.8% -4.1% 19.3% 18.2% 10.7% 3.1% 8.7% 7.8% 17.0% 19.7% 8.8% 12.3% 61.9% -3.5% -3.49%
Gross Margin -14.6% 36.6% 30.2% 27.6% -39.1% 64.8% 68.2% 39.3% 2.5% 69.0% 77.0% 35.8% -22.6% 57.1% 56.4% 29.1% 26.7% 48.1% 1.3% — —
Operating Margin -1.3% -70.4% -98.9% -69.3% -1.8% -36.7% -54.3% -2.2% -2.1% 0.4% 26.2% -46.7% -1.1% 6.7% -15.5% -45.0% -10.5% -24.7% -1.4% — —
Net Margin -2.1% -1.4% -1.3% 2.4% -2.3% -36.2% -67.9% -3.0% -1.1% -24.6% 8.3% -65.0% -1.3% -10.0% -1.8% -63.5% -30.0% -56.7% -1.4% — —
EBITDA Margin -1.7% -1.1% -1.2% -70.2% -1.6% 7.5% -34.0% -2.2% -22.2% 10.6% 29.7% -31.0% -76.8% 14.9% -89.8% -35.5% 49.9% -19.0% -1.1% — —
FCF Margin -57.6% -51.1% -59.9% -45.9% -28.3% -9.7% 1.7% 2.7% 2.9% 2.9% 8.3% 7.7% 7.3% 6.9% 4.0% -0.8% -1.9% -9.7% -38.6% -44.9% -44.92%
OCF Margin -56.4% -49.1% -57.8% -44.1% -27.3% -9.0% 3.5% 5.1% 22.8% 20.0% 20.2% 18.2% 7.4% 7.7% 4.9% -0.1% 21.8% 15.7% -11.0% -8.5% -8.47%
ROA 3Y Avg snapshot only -83.83%
ROIC Economic snapshot only -4.83%
Cash ROA snapshot only -21.77%
Cash ROIC snapshot only -1.31%
CROIC snapshot only -6.95%
NOPAT Margin snapshot only -31.21%
Pretax Margin snapshot only -59.23%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 58.80%
SBC / Revenue snapshot only -0.01%
Valuation
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
P/E Ratio -1.12 -2.37 -2.49 -3.40 -5.07 -10.50 13.95 -3.73 -2.65 -0.21 -1.64 -3.58 -1.67 -1.93 -4.42 -1.93 -3.09 -2.28 -4.94 -3.47 -0.007
P/S Ratio 2.35 3.39 3.70 2.39 2.82 2.11 2.79 5.42 2.81 0.20 0.91 1.20 0.77 0.77 3.90 1.68 1.86 1.71 2.92 2.06 0.007
P/B Ratio -1.51 -2.05 -1.89 -2.14 -1.81 -1.08 -1.09 -1.36 -0.61 -0.05 -0.28 -0.41 -0.27 -0.29 -1.15 -0.54 -0.72 -0.57 -3.77 31.82 -0.002
P/FCF -4.09 -6.64 -6.17 -5.19 -9.97 -21.68 160.43 203.74 97.94 6.93 10.91 15.46 10.60 11.12 96.34 -224.07 -97.21 -17.70 -7.56 -4.58 -4.581
P/OCF — — — — — — 80.33 107.01 12.35 1.00 4.49 6.57 10.47 10.07 80.12 — 8.55 10.91 — — —
EV/EBITDA -1.85 -4.08 -4.07 -2.64 -3.30 -3.46 -6.06 -8.76 -9.41 -5.57 -17.34 61.10 -14.26 -20.06 -12.94 -7.47 -80.61 -24.52 -29.62 160.92 160.917
EV/Revenue 3.09 4.18 4.52 3.12 3.65 3.16 4.15 7.88 4.55 2.38 2.12 2.27 1.74 1.76 5.17 3.05 3.11 3.17 2.90 2.06 2.057
EV/EBIT -1.72 -3.66 -3.71 -5.69 20.43 4.64 3.15 63.04 -7.00 -4.10 -8.46 -33.31 -8.08 -10.18 -10.41 -6.09 -18.00 -11.23 -10.84 -9.12 -9.121
EV/FCF -5.37 -8.19 -7.54 -6.80 -12.92 -32.45 238.49 296.16 158.56 82.55 25.52 29.30 23.85 25.37 127.81 -406.02 -162.49 -32.76 -7.53 -4.58 -4.581
Earnings Yield -89.2% -42.1% -40.2% -29.4% -19.7% -9.5% 7.2% -26.8% -37.7% -4.8% -60.9% -27.9% -59.8% -51.7% -22.6% -51.9% -32.4% -43.9% -20.2% -28.8% -28.79%
FCF Yield -24.5% -15.1% -16.2% -19.3% -10.0% -4.6% 0.6% 0.5% 1.0% 14.4% 9.2% 6.5% 9.4% 9.0% 1.0% -0.4% -1.0% -5.6% -13.2% -21.8% -21.83%
EV/Gross Profit snapshot only 7.211
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Current Ratio 0.36 0.36 0.32 0.43 0.32 0.31 0.29 0.26 0.24 0.25 0.26 0.23 0.14 0.13 0.11 0.13 0.12 0.10 0.02 0.00 0.000
Quick Ratio 0.07 0.06 0.08 0.10 0.04 0.04 0.03 0.03 0.03 0.05 0.07 0.05 0.04 0.06 0.04 0.05 0.05 0.03 0.02 0.00 0.000
Debt/Equity -0.48 -0.48 -0.42 -0.67 -0.54 -0.54 -0.53 -0.62 -0.38 -0.51 -0.38 -0.37 -0.34 -0.38 -0.38 -0.44 -0.49 -0.49 -0.00 0.00 0.000
Net Debt/Equity — — — — — — — — — — — — — — — — — — — 0.00 0.000
Debt/Assets 0.61 0.61 0.59 0.54 0.67 0.69 0.75 1.03 0.66 0.89 0.63 0.71 0.94 0.98 1.17 1.21 1.04 1.15 0.00 0.00 0.000
Debt/EBITDA -0.45 -0.77 -0.74 -0.63 -0.76 -1.15 -1.99 -2.73 -3.61 -5.11 -9.93 28.94 -7.98 -11.35 -3.20 -3.37 -32.99 -11.35 -0.00 0.00 0.000
Net Debt/EBITDA -0.44 -0.77 -0.74 -0.62 -0.75 -1.15 -1.98 -2.73 -3.60 -5.11 -9.93 28.86 -7.92 -11.27 -3.19 -3.35 -32.38 -11.27 0.13 0.00 0.000
Interest Coverage -6.51 -4.45 -5.23 -3.71 1.05 3.67 5.24 0.34 -1.62 -1.55 -0.84 -0.25 -0.87 -0.76 -1.33 -1.37 -0.41 -0.61 -0.82 -0.61 -0.615
Equity Multiplier -0.78 -0.78 -0.71 -1.23 -0.81 -0.77 -0.71 -0.60 -0.58 -0.57 -0.60 -0.52 -0.36 -0.39 -0.32 -0.36 -0.47 -0.43 -0.40 6.02 6.020
Cash Ratio snapshot only 0.000
Debt Service Coverage snapshot only 0.035
Defensive Interval snapshot only 0.0 days
Efficiency & Turnover
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Asset Turnover 0.71 0.71 0.66 0.68 0.68 0.55 0.45 0.35 0.36 0.39 0.52 0.65 0.82 0.87 0.77 0.81 0.93 0.84 1.39 1.01 1.010
Inventory Turnover 1.25 1.23 1.21 1.20 1.06 0.83 0.65 0.48 0.37 0.40 0.45 0.60 1.14 1.44 1.39 1.61 2.36 2.51 4.40 3.83 3.826
Receivables Turnover 6.37 7.53 5.45 5.32 8.55 7.45 5.31 3.44 5.98 4.60 5.10 7.54 10.06 6.40 6.20 6.39 8.90 7.32 19.46 8.70 8.697
Payables Turnover 1.25 1.10 0.90 0.93 0.82 0.63 0.44 0.35 0.23 0.24 0.27 0.33 0.41 0.48 0.52 0.53 0.43 0.43 0.70 0.67 0.667
DSO 57 48 67 69 43 49 69 106 61 79 72 48 36 57 59 57 41 50 19 42 42.0 days
DIO 292 298 302 304 344 438 558 757 982 919 804 607 320 253 263 227 154 146 83 95 95.4 days
DPO 293 330 406 393 448 578 829 1057 1605 1551 1354 1121 897 765 701 691 853 848 521 547 546.9 days
Cash Conversion Cycle 57 16 -37 -20 -61 -91 -202 -194 -562 -553 -478 -465 -540 -455 -380 -407 -658 -653 -419 -410 -409.6 days
Operating Cycle snapshot only 148.5 days
Capital Intensity snapshot only 0.389
Growth (YoY)
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Revenue 1934.8% 2.4% 62.0% 0.9% -27.5% -38.5% -47.2% -58.3% -57.6% -43.1% -4.9% 51.9% 88.6% 92.1% 26.5% 12.6% 12.6% -7.5% -3.4% -28.9% -28.89%
Net Income -39.5% -24.0% 5.6% 66.7% 80.8% 91.4% 1.1% 13.8% 19.3% -1.7% -3.6% 65.0% 17.8% 20.3% -1.0% -1.9% -46.6% -74.0% 35.4% 51.7% 51.73%
EPS -42.3% 77.5% 37.5% 85.6% 88.1% 93.8% 1.1% 28.1% 19.4% -1.7% -3.6% 65.0% 17.8% 20.3% -1.0% -1.8% -10.6% -26.8% 52.9% 62.5% 62.53%
FCF -2396.0% -1.1% -1.1% 8.7% 64.4% 88.3% 1.0% 1.0% 1.0% 1.2% 3.5% 3.4% 3.8% 3.6% -38.3% -1.1% -1.3% -2.3% -10.2% -41.6% -41.58%
EBITDA -29.1% 1.7% 18.7% 29.5% 51.9% 45.2% 67.5% 68.3% 81.5% 73.3% 83.0% 1.1% 52.4% 60.6% -3.1% -13.4% 64.4% -36.1% 76.3% 1.0% 1.02%
Op. Income -13.5% -2.8% -81.0% -18.5% 18.9% 33.4% 50.0% 47.7% 48.7% 43.2% 46.0% 58.4% 57.5% 56.4% 3.7% -32.7% 40.5% 3.8% -3.6% 23.6% 23.64%
OCF Growth snapshot only -52.77%
Asset Growth snapshot only -75.54%
Debt Growth snapshot only -1.00%
Shares Change snapshot only 28.82%
Growth (CAGR)
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Revenue 3Y — — — — — — — 10.2% 7.4% 5.7% -6.7% -13.9% -16.6% -12.4% -14.1% -10.7% -3.5% 0.4% 5.1% 6.8% 6.76%
Revenue 5Y — — — — — — — — — — — — — — — 3.7% 3.2% 16.0% -0.1% -12.6% -12.55%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — 12.5% 9.8% 7.7% 7.6% 37.6% 30.6% 16.9% 18.9% 16.3% 1.2% 2.6% 20.0% 19.1% 6.3% 5.5% 5.55%
Gross Profit 5Y — — — — — — — — — — — — — 4.5% 3.5% 3.1% 3.1% 28.8% 6.0% -7.9% -7.85%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 3.8% 3.4% 5.0% 5.0% 5.6% 5.8% 6.4% 8.5% -20.1% -17.8% -16.3% -15.6% -21.0% -19.0% -20.6% -16.3% -4.3% -5.1% -41.9% -41.8% -41.75%
Assets 5Y -24.1% 50.9% 47.4% 54.2% 51.4% 78.9% 99.8% 1.3% 1.4% 1.2% 1.7% 1.7% 1.9% 2.0% 2.1% 2.7% -12.8% -12.4% -35.1% -34.1% -34.06%
Equity 3Y — — — — — — — — — — — — — — — — — — — — —
Book Value 3Y — — — — — — — — — — — — — — — — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Revenue Stability 0.41 0.59 0.68 0.65 0.57 0.63 0.56 0.36 0.26 0.26 0.28 0.16 0.11 0.18 0.22 0.32 0.49 0.47 0.02 0.35 0.353
Earnings Stability 0.32 0.26 0.25 0.30 0.16 0.19 0.08 0.17 0.07 0.01 0.00 0.00 0.00 0.09 0.05 0.04 0.08 0.45 0.44 0.56 0.562
Margin Stability — — — 0.31 0.45 0.87 0.82 0.41 0.50 0.49 0.44 0.50 0.50 0.54 0.53 0.54 0.74 0.65 0.58 0.62 0.621
Rev. Growth Consistency 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 0 0 0 0 0 0
Earnings Persistence 0.50 0.90 0.98 0.50 0.50 0.50 0.20 0.94 0.92 0.50 0.20 0.50 0.93 0.92 0.50 0.50 0.81 0.50 0.86 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — — — — — — — — — — — — — —
Gross Margin Trend — — — -0.22 -0.07 0.02 0.07 0.08 0.28 0.29 0.34 0.30 0.09 0.06 -0.10 -0.11 -0.03 -0.08 -0.17 -0.15 -0.147
FCF Margin Trend — — — 3.69 0.24 0.57 0.54 0.51 0.46 0.33 0.37 0.29 0.20 0.10 -0.01 -0.06 -0.07 -0.15 -0.45 -0.48 -0.484
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — 9.9% — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
OCF/Net Income 0.27 0.34 0.39 0.63 0.49 0.45 0.17 -0.03 -0.21 -0.21 -0.37 -0.54 -0.16 -0.19 -0.06 0.00 -0.36 -0.21 0.19 0.14 0.143
FCF/OCF 1.02 1.04 1.04 1.04 1.04 1.09 0.50 0.53 0.13 0.14 0.41 0.43 0.99 0.91 0.83 6.69 -0.09 -0.62 3.50 5.30 5.301
FCF/Net Income snapshot only 0.758
OCF/EBITDA snapshot only -6.627
CapEx/Revenue 1.2% 1.9% 2.1% 1.8% 1.0% 0.8% 1.7% 2.4% 19.9% 17.1% 11.9% 10.5% 0.1% 0.7% 0.8% 0.6% 23.7% 25.4% 27.5% 36.4% 36.44%
CapEx/Depreciation snapshot only 1.528
Accruals Ratio -1.09 -0.66 -0.60 -0.18 -0.19 -0.06 0.07 -0.53 -0.46 -0.45 -0.39 -0.33 -0.44 -0.41 -0.71 -0.71 -0.76 -0.76 -0.67 -0.51 -0.513
Sloan Accruals snapshot only 3.987
Cash Flow Adequacy snapshot only -0.232
Dividends & Buybacks
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — 0.0% — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — — —
Total Payout Ratio — — — — — — 0.1% — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -26.8% -13.9% -14.2% -20.8% -12.4% -7.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Shareholder Return -26.8% -13.9% -14.2% -20.8% -12.4% -7.9% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
DuPont Factors
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.17 1.25 1.22 1.28 -3.11 -0.30 0.15 -11.61 1.63 1.66 2.20 4.91 2.15 2.31 1.78 1.75 3.48 2.66 2.20 2.63 2.626
EBIT Margin -1.80 -1.14 -1.22 -0.55 0.18 0.68 1.32 0.12 -0.65 -0.58 -0.25 -0.07 -0.22 -0.17 -0.50 -0.50 -0.17 -0.28 -0.27 -0.23 -0.226
Asset Turnover 0.71 0.71 0.66 0.68 0.68 0.55 0.45 0.35 0.36 0.39 0.52 0.65 0.82 0.87 0.77 0.81 0.93 0.84 1.39 1.01 1.010
Equity Multiplier -1.09 -1.02 -0.88 -0.95 -0.79 -0.78 -0.71 -0.86 -0.68 -0.66 -0.65 -0.56 -0.46 -0.47 -0.44 -0.43 -0.42 -0.41 -0.34 -0.46 -0.459
Per Share
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
EPS (Diluted TTM) $-0.14 $-0.08 $-0.07 $-0.03 $-0.02 $-0.00 $0.00 $-0.02 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.02 $-0.02 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01
Book Value/Share $-0.10 $-0.09 $-0.09 $-0.04 $-0.05 $-0.05 $-0.05 $-0.05 $-0.06 $-0.06 $-0.06 $-0.06 $-0.07 $-0.07 $-0.08 $-0.07 $-0.05 $-0.05 $-0.01 $0.00 $-0.06
Tangible Book/Share $-0.12 $-0.11 $-0.10 $-0.06 $-0.06 $-0.06 $-0.06 $-0.06 $-0.07 $-0.07 $-0.07 $-0.07 $-0.08 $-0.08 $-0.08 $-0.08 $-0.06 $-0.06 $-0.02 $-0.00 $-0.00
Revenue/Share $0.07 $0.05 $0.05 $0.04 $0.03 $0.02 $0.02 $0.01 $0.01 $0.01 $0.02 $0.02 $0.02 $0.03 $0.02 $0.02 $0.02 $0.02 $0.02 $0.01 $0.02
FCF/Share $-0.04 $-0.03 $-0.03 $-0.02 $-0.01 $-0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $-0.00 $-0.00 $-0.00 $-0.01 $-0.01 $-0.00
OCF/Share $-0.04 $-0.03 $-0.03 $-0.02 $-0.01 $-0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $-0.00 $0.00 $0.00 $-0.00 $-0.00 $0.01
Cash/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EBITDA/Share $-0.11 $-0.05 $-0.05 $-0.05 $-0.03 $-0.02 $-0.01 $-0.01 $-0.01 $-0.01 $-0.00 $0.00 $-0.00 $-0.00 $-0.01 $-0.01 $-0.00 $-0.00 $-0.00 $0.00 $0.00
Debt/Share $0.05 $0.04 $0.04 $0.03 $0.02 $0.02 $0.03 $0.03 $0.02 $0.03 $0.02 $0.02 $0.02 $0.03 $0.03 $0.03 $0.03 $0.03 $0.00 $0.00 $0.00
Net Debt/Share $0.05 $0.04 $0.04 $0.03 $0.02 $0.02 $0.03 $0.03 $0.02 $0.03 $0.02 $0.02 $0.02 $0.03 $0.03 $0.03 $0.02 $0.03 $-0.00 $0.00 $0.00
Academic Models
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -21.785
Altman Z-Prime snapshot only -61.492
Piotroski F-Score 3 4 4 5 2 3 4 4 5 3 4 6 5 5 4 2 3 2 3 4 4
Beneish M-Score 618.79 -6.59 -6.19 -3.50 -4.39 -3.21 -2.96 -6.33 -13.80 -4.35 -3.06 -3.01 -4.81 -4.21 -6.98 -5.91 -6.35 -6.52 10.89 — —
Ohlson O-Score snapshot only inf
Net-Net WC snapshot only $-0.00
EVA snapshot only $-496297.97
Credit
Metric Trend Q4'16 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Current
Credit Rating snapshot only B-
Credit Score 12.62 12.53 12.78 12.62 18.29 20.00 20.00 17.01 15.83 15.15 17.18 8.69 16.10 16.46 16.48 12.88 15.70 14.96 17.56 21.28 21.279
Credit Grade snapshot only 16
Credit Trend snapshot only 8.396
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 8
Sector Credit Rank snapshot only 8

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms